Skip to main content
Move the World.
Chloroquine

Lead Image © BestForYou / Adobe Stock

The U.S. Food and Drug Administration plans to begin testing anti-malaria drug chloroquine as a coronavirus treatment, joining several other trials around the world.

President Donald Trump initially announced during a press briefing on March 19 that the FDA had approved the drug and its alternative formulation, hydroxychloroquine, as treatments for the coronavirus.

Currently, there is no approved treatment for COVID-19.

In fact, the drug is FDA approved for treating malaria, but the agency has not yet evaluated it for treating the new respiratory disease.

President Trump later said that the FDA is "continuing to study the drug," a statement confirmed by FDA commissioner Stephen Hahn during the briefing.

"(Chloroquine) is a drug the president has directed us to take a closer look at as to whether an expanded use approach to that could be done, to actually see if that benefits patients," Hahn said.

Chloroquine as a Coronavirus Treatment

Currently, there is no approved treatment for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2.

However, research groups in China, France, and South Korea have reported promising results in trials testing the efficacy of chloroquine, a drug that has been used to treat malaria since 1944.

Research groups in China, France, and South Korea have reported promising results in trials testing the efficacy of chloroquine.

The Chinese group found that the drug showed good antiviral activity — that is, it slowed the replication of the coronavirus — during in vitro tests.

The French study, meanwhile, found a "significant association" between hydroxychloroquine treatment and the reduction or disappearance of the virus in a study involving 36 hospitalized coronavirus patients.

South Korea's COVID-19 Central Clinical Task Force began recommending hydroxychloroquine as a coronavirus treatment as part of its official guidelines in February.

Occasionally, doctors will also prescribe chloroquine off-label as a rheumatoid arthritis treatment — just like another promising coronavirus treatment, sarilumab (brand name Kevzara).

It's possible that the same mechanism that allows both drugs to ease arthritis symptoms — inhibition of the protein interleukin-6 — could enable them to prevent the coronavirus from triggering a potentially deadly overreaction in the immune system.

“What’s also important is not to provide false hope."

Stephen Hahn

Previous studies have found evidence that chloroquine is highly effective at both preventing and treating SARS infections, a closely related coronavirus disease that emerged in China in 2003.

The FDA now plans to test whether chloroquine could benefit coronavirus patients in the setting of a large clinical trial.

Contributing to that effort is German pharmaceutical company Bayer, which has agreed to donate 3 million tablets of its chloroquine drug Resochin to the U.S. government.

One of Many Possibilities

While any step forward along the path to a coronavirus treatment is encouraging, Hahn was quick to temper expectations about chloroquine during the press briefing.

"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."

Still, chloroquine is far from the only potential treatment for the coronavirus — as Hahn pointed out, there's an ongoing coronavirus vaccine trial taking place in Seattle and research into convalescent plasma therapy against COVID-19 is promising.

"We want to assure the American people that the FDA is all hands on deck, as the president mentioned," Hahn said. "We remain steadfast in helping to foster the development of safe and effective therapies for COVID-19."

Still, if chloroquine does prove effective, it could be easier than a brand-new drug to roll-out widely — because it's been around so long, a generic form is available and relatively cheap.

Up Next

Public Health
First Coronavirus Vaccine Is Ready for Human Testing
coronavirus vaccine
Public Health
First Coronavirus Vaccine Is Ready for Human Testing
The experimental coronavirus vaccine, mRNA-1273, began human testing on March 16, several weeks ahead of expectations.

The experimental coronavirus vaccine, mRNA-1273, began human testing on March 16, several weeks ahead of expectations.

Public Health
How to Make 100 Million Doses of Coronavirus Vaccine in a Year
coronavirus vaccine
Public Health
How to Make 100 Million Doses of Coronavirus Vaccine in a Year
Creating a new vaccine is slow and expensive. One biotech firm thinks a “plug-and-play” vaccine could change that.

Creating a new vaccine is slow and expensive. One biotech firm thinks a “plug-and-play” vaccine could change that.

Public Health
Gates Foundation Funds At-Home Coronavirus Testing Project
coronavirus testing
Public Health
Gates Foundation Funds At-Home Coronavirus Testing Project
The Gates Foundation is funding an at-home coronavirus testing project in Seattle, with the goal of testing thousands of people for COVID-19 daily.

The Gates Foundation is funding an at-home coronavirus testing project in Seattle, with the goal of testing thousands of people for COVID-19 daily.

Public Health
Blood Plasma From Coronavirus Survivors Could Save Lives
coronavirus survivors
Public Health
Blood Plasma From Coronavirus Survivors Could Save Lives
A drug company is using the blood plasma of coronavirus survivors to develop a treatment for those still battling the disease.

A drug company is using the blood plasma of coronavirus survivors to develop a treatment for those still battling the disease.

Public Health
Experts Unveil “Breakthrough” Map of Key Coronavirus Protein
Experts Unveil “Breakthrough” Map of Key Coronavirus Protein
Public Health
Experts Unveil “Breakthrough” Map of Key Coronavirus Protein
Scientists have created the first atomic-scale 3D map of 2019-nCoV’s spike protein, the part of the coronavirus that infiltrates human cells.

Scientists have created the first atomic-scale 3D map of 2019-nCoV’s spike protein, the part of the coronavirus that infiltrates human cells.

Public Health
What Is Protecting Kids Against the Coronavirus?
children coronavirus
Public Health
What Is Protecting Kids Against the Coronavirus?
Something is protecting kids against the coronavirus, and researchers want to figure out what it is so they can use it to develop a treatment.

Something is protecting kids against the coronavirus, and researchers want to figure out what it is so they can use it to develop a treatment.

Computer Science
Our Spare Computer Is Helping Fight Coronavirus. Yours Can, Too.
fight coronavirus
Computer Science
Our Spare Computer Is Helping Fight Coronavirus. Yours Can, Too.
Help fight the coronavirus by donating your spare computing power to [email protected], which will use it to run valuable protein-folding simulations.

Help fight the coronavirus by donating your spare computing power to [email protected], which will use it to run valuable protein-folding simulations.

Public Health
More Than $1 Million in Prizes For Coronavirus Solutions
coronavirus solutions
Public Health
More Than $1 Million in Prizes For Coronavirus Solutions
Emergent Ventures is awarding more than $1 million in coronavirus prizes to people who make significant progress in combating COVID-19.

Emergent Ventures is awarding more than $1 million in coronavirus prizes to people who make significant progress in combating COVID-19.

The Brain
Stimulating Monkeys’ Brains Snaps Them out of Unconsciousness
monkey consciousness
The Brain
Stimulating Monkeys’ Brains Snaps Them out of Unconsciousness
Researchers found that they could induce a state of consciousness in an unconscious monkey by electrically stimulating a specific part of the animal’s brain.

Researchers found that they could induce a state of consciousness in an unconscious monkey by electrically stimulating a specific part of the animal’s brain.